CLRPF
Price
$2.85
Change
-$0.00 (-0.00%)
Updated
Jul 29 closing price
Capitalization
920.08M
ENLV
Price
$1.54
Change
+$0.12 (+8.45%)
Updated
Jul 30, 04:59 PM (EDT)
Capitalization
33.87M
19 days until earnings call
Interact to see
Advertisement

CLRPF vs ENLV

Header iconCLRPF vs ENLV Comparison
Open Charts CLRPF vs ENLVBanner chart's image
Clarity Pharmaceuticals
Price$2.85
Change-$0.00 (-0.00%)
Volume$7.7K
Capitalization920.08M
Enlivex Therapeutics
Price$1.54
Change+$0.12 (+8.45%)
Volume$521
Capitalization33.87M
CLRPF vs ENLV Comparison Chart in %
Loading...
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRPF vs. ENLV commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRPF is a Buy and ENLV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (CLRPF: $2.85 vs. ENLV: $1.42)
Brand notoriety: CLRPF and ENLV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRPF: 105% vs. ENLV: 521%
Market capitalization -- CLRPF: $920.08M vs. ENLV: $33.87M
CLRPF [@Biotechnology] is valued at $920.08M. ENLV’s [@Biotechnology] market capitalization is $33.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $315.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRPF’s FA Score shows that 0 FA rating(s) are green whileENLV’s FA Score has 1 green FA rating(s).

  • CLRPF’s FA Score: 0 green, 5 red.
  • ENLV’s FA Score: 1 green, 4 red.
According to our system of comparison, ENLV is a better buy in the long-term than CLRPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRPF’s TA Score shows that 6 TA indicator(s) are bullish while ENLV’s TA Score has 5 bullish TA indicator(s).

  • CLRPF’s TA Score: 6 bullish, 3 bearish.
  • ENLV’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CLRPF is a better buy in the short-term than ENLV.

Price Growth

CLRPF (@Biotechnology) experienced а +5.75% price change this week, while ENLV (@Biotechnology) price change was +20.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.59%. For the same industry, the average monthly price growth was +14.57%, and the average quarterly price growth was +40.08%.

Reported Earning Dates

ENLV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (-3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLRPF($920M) has a higher market cap than ENLV($33.9M). ENLV YTD gains are higher at: 21.368 vs. CLRPF (5.360). ENLV has higher annual earnings (EBITDA): -14.04M vs. CLRPF (-66.98M).
CLRPFENLVCLRPF / ENLV
Capitalization920M33.9M2,714%
EBITDA-66.98M-14.04M477%
Gain YTD5.36021.36825%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A20.6M-
Total DebtN/A503K-
FUNDAMENTALS RATINGS
ENLV: Fundamental Ratings
ENLV
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLRPFENLV
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARYDX13.490.22
+1.66%
American Century Global Real Estate R6
VICEX24.070.04
+0.17%
USA Mutuals Vice Investor
PJGZX23.020.02
+0.09%
PGIM Jennison Focused Value Z
OTCGX22.98-0.13
-0.56%
MFS Mid Cap Growth R1
IEOHX17.66-0.13
-0.73%
Voya Large Cap Growth Port I

CLRPF and

Correlation & Price change

A.I.dvisor tells us that CLRPF and ENLV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and ENLV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRPF
1D Price
Change %
CLRPF100%
N/A
ENLV - CLRPF
22%
Poorly correlated
+12.70%
JBPHF - CLRPF
14%
Poorly correlated
N/A
MLTX - CLRPF
11%
Poorly correlated
-3.89%
TELIF - CLRPF
10%
Poorly correlated
-8.36%
ACUT - CLRPF
9%
Poorly correlated
+3.42%
More

ENLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENLV
1D Price
Change %
ENLV100%
+12.70%
APVO - ENLV
36%
Loosely correlated
-2.72%
OCUL - ENLV
29%
Poorly correlated
-2.73%
KURA - ENLV
28%
Poorly correlated
+2.82%
JANX - ENLV
26%
Poorly correlated
-5.40%
HRTX - ENLV
26%
Poorly correlated
-0.54%
More